Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
Background The role of adjuvant chemotherapy (ACT) for patients with stage IB–IIA non‐small cell lung cancer (NSCLC) according to the eighth edition of the AJCC TNM staging system remains controversial. Methods Data were collected from patients with NSCLC stage IB–IIA according to the eighth edition...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2021-01-01
|
| Edice: | Thoracic Cancer |
| Témata: | |
| On-line přístup: | https://doi.org/10.1111/1759-7714.13685 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
